In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Where does the subcutaneous ICD fit in my patient practice?

Add to calendar17/02/20150:00 17/02/20150:00 Europe/Paris Where does the subcutaneous ICD fit in my patient practice? European Heart Rhythm Association DD/MM/YYYY


By the end of the webinar, you should be able to:

- Understand how the S-ICD is implanted, and how the arrhythmia algorithm and the S-ICD signal discriminate arrhythmias to deliver appropriate therapy and avoid inappropriate therapy.
- Understand the morbidity benefits of subcutaneous ICD therapy
- Understand which pt population cannot benefit from subcutaneous ICD
- Appreciate effectiveness of the subcutaneous ICD to terminate ventricular arrhythmias
- Appreciate subcutaneous ICD performance in different patient populations and disease states

But also to know:

- How to identify & screen patients appropriately for the subcutaneous ICD
- How to implant the S-ICD
- How to avoid pitfalls that diminish it's proper function
- How to avoid complications
- How to manage inappropriate shocks

Lucas Boersma, Pier Lambiase and Alessandro Capucci

The EHRA Webinars are designed to help you improve your daily practice!

The format includes a case based presentation, online assessment and live discussions with the two key opinion leaders who will give you some useful tips for your daily clinical practice.


- ESC guidelines

- EHRA Key Reference Library

- Weiss R, Knight BP, Gold MR et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013, 27;128(9):944-53.

- Lambiase PD, Barr C, Theuns DA et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014;35(25):1657-65.

- Kooiman KM, Knops RE, Olde NL, Wilde AA, de G, Jr. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. Heart Rhythm 2014 March;11(3):426-34.


This programme is supported by Boston Scientific in the form of unrestricted educational grants.
The scientific programme has not been influenced in any way by its sponsor.